Literature DB >> 8378090

Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer.

M Mori1, G F Barnard, R J Staniunas, J M Jessup, G D Steele, L B Chen.   

Abstract

Prothymosin alpha (PT-alpha) is a nuclear protein involved in cell proliferation. Transcription of PT-alpha has been reported to be regulated by the c-myc gene in vitro. We identified PT-alpha as being overexpressed in a human colon cancer minus normal mucosa subtraction cDNA library. Northern blot (messenger RNA) analysis showed that both PT-alpha and c-myc genes were overexpressed in human colorectal cancers compared with adjacent normal tissues. Immunohistochemical studies for PT-alpha and c-myc supported these findings. There was no correlation between PT-alpha or c-myc messenger RNA expression and Dukes' stage of colorectal cancer; or between either of these two and actin messenger RNA expression. There was, however, a significant correlation between the PT-alpha expression and c-myc expression (P < 0.001). These findings support the hypothesis that PT-alpha gene transcription may be associated with, and possibly under the control of, the c-myc gene in human colorectal cancers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378090

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.

Authors:  M A Cotter; E S Robertson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Immunohistochemical expression of beta-human chorionic gonadotropin in colorectal carcinoma.

Authors:  A Kido; M Mori; Y Adachi; H Yukaya; T Ishida; K Sugimachi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  SSO Clinical Award Lecture. The surgical oncologist as a key translator of basic biology to patients with gastrointestinal cancer: asking the right questions.

Authors:  G Steele
Journal:  Ann Surg Oncol       Date:  1994-05       Impact factor: 5.344

4.  The pattern of prothymosin alpha gene expression coincides with that of myc proto-oncogenes during mouse embryogenesis.

Authors:  J Moll; P Schmid; G Sansig; H van der Putten
Journal:  Histochem J       Date:  1996-01

5.  Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy.

Authors:  Eiki Ojima; Yasuhiro Inoue; Chikao Miki; Masaki Mori; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

6.  Prothymosin alpha modulates the interaction of histone H1 with chromatin.

Authors:  Z Karetsou; R Sandaltzopoulos; M Frangou-Lazaridis; C Y Lai; O Tsolas; P B Becker; T Papamarcaki
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

7.  Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?

Authors:  P C Mol; R H Wang; D W Batey; L A Lee; C V Dang; S L Berger
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

8.  Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.

Authors:  Ranju Ralhan; Leroi V Desouza; Ajay Matta; Satyendra Chandra Tripathi; Shaun Ghanny; Siddartha Datta Gupta; Sudhir Bahadur; K W Michael Siu
Journal:  Mol Cell Proteomics       Date:  2008-03-13       Impact factor: 5.911

9.  Elongation factor 1 gamma mRNA expression in oesophageal carcinoma.

Authors:  K Mimori; M Mori; H Inoue; H Ueo; K Mafune; T Akiyoshi; K Sugimachi
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

10.  Increased expression of prothymosin-α, independently or combined with TP53, correlates with poor prognosis in colorectal cancer.

Authors:  Meng Zhang; Feifei Cui; Su Lu; Huijun Lu; Tao Jiang; Jian Chen; Xuemei Zhang; Yubiao Jin; Zhihai Peng; Huamei Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.